On the occasion of World Diabetes Day on 14 November 2025, the WHO released its first global guideline specifically addressing the care of women with diabetes during pregnancy—whether pre-existing (type 1 or type 2) or newly diagnosed in pregnancy (gestational diabetes).

According to WHO, diabetes in pregnancy significantly increases the risk of pre-eclampsia, obstructed labour, neonatal hypoglycaemia, stillbirth and long-term metabolic disorders in both mother and child. The burden is highest in low- and middle-income countries, where access to specialised maternal-diabetes services remains limited.

The new guideline consolidates evidence-based recommendations on diagnosis, lifestyle management, glucose monitoring and pharmacological therapy. WHO emphasises individualised care, includin

See Full Page